EZH2 and neoplasm: For instance, persistent H3K27me3 marks—which reflect transcriptional repression of tumor suppressor genes mediated by EZH2/PRC2 activity—provide a direct mechanistic rationale for combining EZH2 inhibitors with DNA-demethylating agents.